Hepatocyte Growth Factor and Met in Tumour Invasion-metastasis: From Mechanisms to Cancer Prevention

作者: Kunio Matsumoto , Toshikazu Nakamura

DOI: 10.1007/0-306-48388-2_6

关键词:

摘要: Hepatocyte growth factor (HGF), a ligand for c-met proto-oncogene product of receptor tyrosine kinase, exhibits powerful motogenic and angiogenic activities. The utilization the HGF-Met system in cancer cells confers invasive metastatic potentials. HGF potently enhances dissociation cells, cell-matrix interaction, extracellular matrix breakdown, invasion, angiogenesis, all critical events cascade. Tumour-stromal interaction mediated by HGF, aberrant expression Met, autocrine or mutational activation Met are tightly associated with carcinogenesis malignant progression wide variety tumours. Notably, NK4, four kringle-antagonist signaling inhibited tumour invasion metastasis. possibility has arisen that an HGF-antagonist can serve as new therapeutic strategyfor treatment patients. In normal tissues, supports dynamic tissue remodeling regeneration clinical application organ failure/fibrosis will be initiated within few years. These “two-pronged approaches” regarding lead to repair perhaps even prevention cancer.

参考文章(253)
A. van den Hooff, Stromal involvement in malignant growth. Advances in Cancer Research. ,vol. 50, pp. 159- 196 ,(1988) , 10.1016/S0065-230X(08)60437-6
Chuman H, Tsuneyoshi M, Shinohara N, Naka T, Iwamoto Y, Ushijima M, Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Modern Pathology. ,vol. 10, pp. 832- 838 ,(1997)
R P Narsimhan, L Naldini, P M Comoglio, E Vigna, G K Michalopoulos, G Gaudino, R Zarnegar, Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene. ,vol. 6, pp. 501- 504 ,(1991)
L. Naldini, K.M. Weidner, E. Vigna, G. Gaudino, A. Bardelli, C. Ponzetto, R.P. Narsimhan, G. Hartmann, R. Zarnegar, G.K. Michalopoulos, Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. The EMBO Journal. ,vol. 10, pp. 2867- 2878 ,(1991) , 10.1002/J.1460-2075.1991.TB07836.X
Carina Seidel, Magne Børset, Henrik Hjorth-Hansen, Anders Sundan, Anders Waage, Role of hepatocyte growth factor and its receptor c-met in multiple myeloma. Medical Oncology. ,vol. 15, pp. 145- 153 ,(1998) , 10.1007/BF02821933
Teruyo Sakakura, New Aspects of Stroma-Parenchyma Relations in Mammary Gland Differentiation International Review of Cytology. ,vol. 125, pp. 165- 202 ,(1991) , 10.1016/S0074-7696(08)61219-X
Timothy L. Ratliff, Robin T. Vollmer, Peter A. Humphrey, Xiaopei Zhu, Mark L. Day, Paul E. Swanson, Reza Zarnegar, Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. American Journal of Pathology. ,vol. 147, pp. 386- 396 ,(1995)
I. Lubensky, H. Neumann, Zhengping Zhuang, L. Schmidt, K. Junker, G. Glenn, M. Jeffers, W. M. Linehan, G. Vande Woude, G. Weirich, M. Walther, B. Zbar, P. Choyke, Two North American Families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene Cancer Research. ,vol. 58, pp. 1719- 1722 ,(1998)
N Weidner, Intratumor microvessel density as a prognostic factor in cancer. American Journal of Pathology. ,vol. 147, pp. 9- 19 ,(1995)